High dose pancreatic enzymes in cystic fibrosis.

Abstract

Seven patients with cystic fibrosis taking high doses of pancreatin supplements were assessed to determine whether this dose was necessary to achieve adequate fat absorption. Patients reduced their intake from a group mean of 45 to 21 capsules a day. Five patients did not have any significant alteration in fat malabsorption while taking the reduced enzyme dose.

• Authors: P J Robinson, P D Sly
• Journal: Archives of disease in childhood (Arch Dis Child) Vol. 65 Issue 3 Pg. 311-2 (Mar 1990) ISSN: 1468-2044 [Electronic] England
• PMID: 2334211 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Dietary Fats
• Pancreatin

Topics

• Adolescent
• Child
• Cystic Fibrosis (metabolism, therapy)
• Dietary Fats (metabolism)
• Female
• Humans
• Intestinal Absorption (drug effects)
• Male
• Pancreatin (administration & dosage, therapeutic use)